Objective To assess the associations between coronavirus disease 2019 (COVID-19)
infection and thromboembolism including myocardial infarction (MI), ischemic stroke, deep …

Background Evidence supports an excess of deaths during the COVID-19 pandemic. We
report the incidence and mortality of thrombo-embolic events (TE) during the COVID-19 …

Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …

Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …

Introduction Infection with SARS-CoV-2 is typically compared with influenza to contextualize
its health risks. SARS-CoV-2 has been linked with coagulation disturbances including …

Arterial thrombotic disease (atherosclerotic cardiovascular disease, CVD) and venous
thromboembolism (VTE)(comprising of deep vein thrombosis (DVT) and pulmonary …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …

It is well established that the risk of venous thromboembolism is high in coronavirus disease
19 (COVID-19). The frequency of arterial thromboembolic events (ATEs) in hospitalized …

Background There are few data on the incidence of thrombosis among COVID-19 cases,
with most research concentrated on hospitalised patients. We aimed to estimate the …

Background Severely ill patients with SARS-CoV-2 have an increased risk of venous
thromboembolism (VTE) ie, deep vein thrombosis and pulmonary embolism. However, the …